Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
G Ambrosio, … , M Chiariello, M Triggiani
G Ambrosio, … , M Chiariello, M Triggiani
Published June 1, 1994
Citation Information: J Clin Invest. 1994;93(6):2408-2416. https://doi.org/10.1172/JCI117248.
View: Text | PDF
Research Article

Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.

  • Text
  • PDF
Abstract

Platelet-activating factor (PAF) can exert profound inflammatory effects at very low concentrations. In plasma, PAF is hydrolyzed to lyso-PAF by acetylhydrolase, an enzyme that circulates bound to LDL. Previous studies suggest that oxygen radicals may act synergistically with PAF to potentiate tissue injury. However, mechanisms underlying this interaction have not been elucidated. In this study we investigated whether oxygen radicals may inactivate PAF acetylhydrolase. PAF acetylhydrolase activity was measured in human plasma and purified LDL before and after exposure to radicals (10-20 nmol/min per ml) generated by xanthine/xanthine oxidase. Oxygen radicals induced > 50% loss of PAF acetylhydrolase activity within 60 s and almost complete inactivation by 10 min. This phenomenon was irreversible and independent of oxidative modification of LDL. Inactivation occurred without changes in the affinity constant of the enzyme (Km was 17.9 microM under control conditions and 15.1 microM after exposure to oxygen radicals). Inactivation was prevented by the scavengers superoxide dismutase or dimethylthiourea or by the iron chelator deferoxamine. Thus, superoxide-mediated, iron-catalyzed formation of hydroxyl radicals can rapidly and irreversibly inactivate PAF acetylhydrolase. Since concomitant production of PAF and oxygen radicals can occur in various forms of tissue injury, inactivation of acetylhydrolase might represent one mechanism by which oxygen radicals may potentiate and prolong the proinflammatory effects of PAF.

Authors

G Ambrosio, A Oriente, C Napoli, G Palumbo, P Chiariello, G Marone, M Condorelli, M Chiariello, M Triggiani

×

Total citations by year

Year: 2025 2021 2019 2018 2016 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 1 3 2 1 1 2 4 2 3 6 1 1 2 4 2 4 6 9 4 9 9 16 8 7 108
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (108)

Title and authors Publication Year
Synergistic Effects of a Novel Combination of Natural Compounds Prevent H2O2-Induced Oxidative Stress in Red Blood Cells
Benincasa G, Bontempo P, Trama U, Napoli C
International Journal of Molecular Sciences 2025
Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
P Detopoulou, CA Demopoulos, S Antonopoulou
Nutrients 2021
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
I Alecu, SA Bennett
Frontiers in neuroscience 2019
The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats
G Wójcicka, M Zaręba, A Warpas, A Jamroz-Wiśniewska, M Rusek, G Czechowska, J Bełtowski
European Journal of Pharmacology 2019
Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives
R Lordan, A Tsoupras, I Zabetakis, CA Demopoulos
Molecules (Basel, Switzerland) 2019
Met117 oxidation leads to enhanced flexibility of cardiovascular biomarker- lipoprotein- associated phospholipase A 2 and reduced substrate binding affinity with platelet-activating factor
AB Gurung, A Bhattacharjee
International Journal of Biological Macromolecules 2018
Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome
PR Ames, LL Lopez, M Merashli, E Matsuura
Autoimmunity Highlights 2018
LDL-Related Intolerance to Glucose, Diastolic Hypertension and Additive Effects of Smoking Were Found with Three Female Study Groups
RM Korth
Health 2016
The Enzymes
DM Stafforini
Protein Prenylation PART A 2015
Exploiting the anti-inflammatory properties of olive (Olea europaea) in the sustainable production of functional food and neutraceuticals
C Nasopoulou, HC Karantonis, M Detopoulou, CA Demopoulos, I Zabetakis
Phytochemistry Reviews 2014
Women with overweight, mixed hyperlipidemia, intolerance to glucose and diastolic hypertension
RM Korth
Health 2014
High-yield enzymatic bioconversion of hydroquinone to α-arbutin, a powerful skin lightening agent, by amylosucrase
DH Seo, JH Jung, SJ Ha, HK Cho, DH Jung, TJ Kim, NI Baek, SH Yoo, CS Park
Applied Microbiology and Biotechnology 2012
Posztkondicionálás – A távoli szervi dysfunctiók ellenszere?
P Ónody, O Rosero, T Kovács, D Garbaisz, V Hegedüs, G Lotz, L Harsányi, A Szijártó
Magyar Sebészet (Hungarian Journal of Surgery) 2012
Air plasma for medical applications
SP Kuo
Journal of Biomedical Science and Engineering 2012
Applications of Air Plasma for Wound Bleeding Control and Healing
SP Kuo, CY Chen, CS Lin, SH Chiang
IEEE Transactions on Plasma Science 2012
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation
PR Kvietys, DN Granger
Free radical biology & medicine 2011
Plasma for Bio-Decontamination, Medicine and Food Security
Z Machala, K Hensel, Y Akishev
2011
Wound Bleeding Control by Low Temperature Air Plasma
SP Kuo, CY Chen, CS Lin, SH Chiang
IEEE Transactions on Plasma Science 2010
Extracellular phospholipases in atherosclerosis
SA Karabina, S Gora, R Atout, E Ninio
Biochimie 2010
The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity
G Wójcicka, A Jamroz-Wiśniewska, A Marciniak, E Łowicka, J Bełtowski
Life Sciences 2010
Blood Clotting by Low-Temperature Air Plasma
CY Chen, HW Fan, SP Kuo, J Chang, T Pedersen, TJ Mills, CC Huang
IEEE Transactions on Plasma Science 2009
Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: The ATTICA Study
AD Tselepis, DB Panagiotakos, C Pitsavos, CC Tellis, C Chrysohoou, C Stefanadis
Atherosclerosis 2009
Contribution of a portable air plasma torch to rapid blood coagulation as a method of preventing bleeding
SP Kuo, O Tarasenko, J Chang, S Popovic, CY Chen, HW Fan, A Scott, M Lahiani, P Alusta, JD Drake, M Nikolic
New Journal of Physics 2009
Mast Cells and Basophils
GH Caughey
Asthma and COPD 2009
Differential expression of platelet-activating factor acetylhydrolase in lung macrophages
KM Howard
American journal of physiology. Lung cellular and molecular physiology 2009
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
CC Tellis, AD Tselepis
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009
Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
DM Stafforini
Cardiovascular Drugs and Therapy 2008
Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation
AN MacRitchie, AA Gardner, SM Prescott, DM Stafforini
The FASEB Journal 2007
Plasma PAF-acetylhydrolase: An unfulfilled promise?
SA Karabina, E Ninio
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2006
The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2
S Gora, G Lambeau, JG Bollinger, M Gelb, E Ninio, SA Karabina
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2006
Phospholipid mediators in the vessel wall: involvement in atherosclerosis
E Ninio
Current Opinion in Clinical Nutrition and Metabolic Care 2005
Plasma platelet-activating factor acetylhydrolase activity in critically ill patients*
RA Claus, S Russwurm, B Dohrn, M Bauer, W L??sche
Critical Care Medicine 2005
Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase
HC Neto, DM Stafforini, SM Prescott, GA Zimmerman
Memórias do Instituto Oswaldo Cruz 2005
Release of Free F 2 -isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases
DM Stafforini, JR Sheller, TS Blackwell, A Sapirstein, FE Yull, TM McIntyre, JV Bonventre, SM Prescott, LJ Roberts
The Journal of biological chemistry 2005
Occurence of lipid bodies in canine type II pneumocytes during hypothermic lung ischemia
M Ochs, H Fehrenbach, J Richter
The Anatomical Record 2004
Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression
JL Beaudeux, T Said, E Ninio, F Ganné, J Soria, J Delattre, C Soria, A Legrand, J Peynet
Clinica Chimica Acta 2004
Plasma platelet activating factor-acetylhydrolase (PAF-AH)
K Karasawa, A Harada, N Satoh, K Inoue, M Setaka
Progress in Lipid Research 2003
High density lipoprotein can modulate the inhibitory effect of oxLDL on prostacyclin generation by rat aorta in vitro
MM Mahfouz, FA Kummerow
Prostaglandins & Other Lipid Mediators 2003
Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus
T Kujiraoka, T Iwasaki, M Ishihara, M Ito, M Nagano, A Kawaguchi, S Takahashi, J Ishi, M Tsuji, T Egashira, IP Stepanova, NE Miller, H Hattori
Journal of lipid research 2003
Role of Monocytes in Atherogenesis
B Østerud, E Bjørklid
Physiological reviews 2003
Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22phox in lymphoblast cell lines
AI Pettit, RK Wong, V Lee, S Jennings, PA Quinn, LL Ng
Journal of Hypertension 2002
Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase
K Wang, PV Subbaiah
Biochemical Journal 2002
Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation
C Martínez-Salgado, N Eleno, P Tavares, A Rodríguez-Barbero, J García-Criado, JP Bolaños, JM López-Novoa
Kidney International 2002
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis
Guy A Zimmerman, Thomas M McIntyre, Stephen M Prescott, Diana M Stafforini
Critical Care Medicine 2002
Apolipoprotein A-I Milano and Apolipoprotein A-I Paris Exhibit an Antioxidant Activity Distinct from That of Wild-Type Apolipoprotein A-I
JK Bielicki, MN Oda
Biochemistry 2002
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
TM Forte, G Subbanagounder, JA Berliner, PJ Blanche, AO Clermont, Z Jia, MN Oda, RM Krauss, JK Bielicki
Journal of lipid research 2002
PAF acetylhydrolase gene polymorphisms and asthma severity
DM Stafforini
Pharmacogenomics 2001
Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1
VA Ploplis, I Cornelissen, MJ Sandoval-Cooper, L Weeks, FA Noria, FJ Castellino
The American Journal of Pathology 2001
Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure
JK Bielicki, LJ Knoff, DL Tribble, TM Forte
Atherosclerosis 2001
The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase
TW Kuijpers, JM van Berg, AT Tool, D Roos
Clinical & Experimental Immunology 2001
Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H2O2 from DNA damage
A Tselepis, PT Doulias, E Lourida, G Glantzounis, E Tsimoyiannis, D Galaris
Free radical biology & medicine 2001
Environmental Stressors in Health and Disease
B Halliwell
Environmental Stressors in Health and Disease 2001
Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia
R Jehle, M Schlame, C Büttner, B Frey, P Sinha, B Rüstow
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2001
Roles for platelet-activating factor and ·NO-derived oxidants causing neutrophil adherence after CO poisoning
SR Thom, D Fisher, Y Manevich
American journal of physiology. Heart and circulatory physiology 2001
Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E–Deficient Mice
R Quarck, BD Geest, D Stengel, A Mertens, M Lox, G Theilmeier, C Michiels, M Raes, H Bult, D Collen, PV Veldhoven, E Ninio, P Holvoet
Circulation 2001
Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome
F Trimoreau, B François, A Desachy, A Besse, P Vignon, Y Denizot
Mediators of Inflammation 2000
Platelet-activating factor acetylhydrolases in health and disease
LW Tjoelker, DM Stafforini
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2000
Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells
C Napoli, O Quehenberger, FD Nigris, P Abete, CK Glass, W Palinski
The FASEB Journal 2000
Deregulated platelet‐activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy
Y Denizot, C Aupetit, F Bridoux, JC Alphonse, M Cogné, JC Aldigier
Nephrology Dialysis Transplantation 2000
Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma
DM Stafforini, T Numao, A Tsodikov, D Vaitkus, T Fukuda, N Watanabe, N Fueki, TM McIntyre, GA Zimmerman, S Makino, SM Prescott
Journal of Clinical Investigation 1999
Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis
P Holvoet
Expert Opinion on Investigational Drugs 1999
Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers
PV Peplow
Prostaglandins, Leukotrienes and Essential Fatty Acids 1999
Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits
C Napoli, C Cicala, FP D'Armiento, F Roviezzo, P Somma, F Nigris, P Zuliani, M Bucci, L Aleotti, A Casini, F Franconi, G Cirino
General Pharmacology: The Vascular System 1999
Reperfusion injury: Experimental evidence and clinical implications
G Ambrosio, I Tritto
American Heart Journal 1999
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-l-carnitine
M Triggiani, A Oriente, P Golino, M Gentile, C Battaglia, G Brevetti, G Marone
Biochemical Pharmacology 1999
Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma
VS Subramanian, J Goyal, M Miwa, J Sugatami, M Akiyama, M Liu, PV Subbaiah
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1999
Augmentation of Ultraviolet B Radiation-induced Tumor Necrosis Factor Production by the Epidermal Platelet-activating Factor Receptor
LC Dy, Y Pei, JB Travers
The Journal of biological chemistry 1999
1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats
C Napoli, S Salomone, T Godfraind, W Palinski, DM Capuzzi, G Palumbo, FP DArmiento, R Donzelli, F de Nigris, RL Capizzi, M Mancini, JS Gonnella, A Bianchi
Stroke; a journal of cerebral circulation 1999
Roles of Plasma Platelet-Activating Factor Acetylhydrolase in Allergic, Inflammatory, and Atherosclerotic Diseases
Y Yamada, M Yokota
Japanese Circulation Journal 1998
Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: Is it an additional marker of perinatal asphyxia?
M AkisÜ, NÜ KÜLtÜRsay, I ÇOker, A HÜSeyinov
Pediatrics International 1998
Involvement of superoxide and nitric oxide on airway inflammation and hyperresponsiveness induced by diesel exhaust particles in mice
HB Lim, T Ichinose, Y Miyabara, H Takano, Y Kumagai, N Shimojyo, JL Devalia, M Sagai
Free radical biology & medicine 1998
Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis
P Holvoet, D Collen
Atherosclerosis 1998
Familial hypercholesterolaemia and platelet-activating factor acetylhydrolase: difference between the homozygous and heterozygous form
Napoli
European Journal of Clinical Investigation 1998
High density associated enzymes: their role in vascular biology
M Navab, SY Hama, GP Hough, CC Hedrick, R Sorenson, BN la Du, JA Kobashigawa, GC Fonarow, JA Berliner, H Laks, AM Fogelman
Current Opinion in Lipidology 1998
Secretory PAF-acetylhydrolase of the rat hepatobiliary system: characterization and partial purification
SI Svetlov, KM Howard, MS Debuysere, MS Olson
AJP Gastrointestinal and Liver Physiology 1998
Expression of the Platelet-activating Factor Receptor Results in Enhanced Ultraviolet B Radiation-induced Apoptosis in a Human Epidermal Cell Line
LA Barber, DF Spandau, SC Rathman, RC Murphy, CA Johnson, SW Kelley, SA Hurwitz, JB Travers
The Journal of biological chemistry 1998
Yearbook of Intensive Care and Emergency Medicine 1998
JL Vincent
1998
Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions
C Napoli, FP D'Armiento, FP Mancini, A Postiglione, JL Witztum, G Palumbo, W Palinski
Journal of Clinical Investigation 1997
Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein
C Napoli, M Triggiani, G Palumbo, M Condorelli, M Chiariello, G Ambrosio
Basic Research in Cardiology 1997
Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein
A Graham, DG Hassall, S Rafique, JS Owen
Atherosclerosis 1997
Effect of low density lipoprotein fatty acid composition on copper-induced peroxidation: 1H-nuclear magnetic resonance analysis
G Corso, E Trivellone, A Motta, A Postiglione, FP Mancinia, V Carbone, C Napoli
Clinica Chimica Acta 1997
Platelet-Activating Factor (PAF) Up-Regulates Plasma and Tissue PAF-Acetylhydrolase Activity in the Rat: Effect of Cycloheximide
H Wang, XD Tan, XW Qu, H Chang, DG Remick, F Gonzalez-Crussi, W Hsueh
Pediatric Research 1997
Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia
C Napoli, G Ambrosio, N Scarpato, G Corso, G Palumbo, FP D'Armiento, FP Mancini, A Malorni, S Formisano, A Ruocco, A Calí, M Chiariello
American Heart Journal 1997
Role of Platelet-Actlvatlng-Factor (PAF) on Cellular Responses after Stimulation with Leptospire Lipopolysaccharide
E Isogai, K Hirose, K Kimura, S Hayashi, T Kubota, N Fujii, H Isogai
Microbiology and Immunology 1997
Characterization of Platelet-activating Factor Acetylhydrolase in Human Bronchoalveolar Lavage
M Triggiani, VA MARINO, M Sofia, S Faraone, G Ambrosio, L Carratù, G Marone
American journal of respiratory and critical care medicine 1997
Occurrence of the same peroxidative compounds in low density lipoprotein and in atherosclerotic lesions from a homozygous familial hypercholesterolemic patient: a case report
C Napoli, FP D'Armiento, G Corso, G Ambrosio, G Palumbo, P Zuliani, A Malorni, G Gallotta, S Somma, A Postiglione, M Chiariello
International Journal of Cardiology 1997
Loss of ATP Diphosphohydrolase Activity with Endothelial Cell Activation
SC Robson, E Kaczmarek, JB Siegel, D Candinas, K Koziak, M Millan, WW Hancock, FH Bach
Journal of Experimental Medicine 1997
Novel Function of Lecithin-Cholesterol Acyltransferase: HYDROLYSIS OF OXIDIZED POLAR PHOSPHOLIPIDS GENERATED DURING LIPOPROTEIN OXIDATION
J Goyal, K Wang, M Liu, PV Subbaiah
The Journal of biological chemistry 1997
Platelet-activating Factor Acetylhydrolases
DM Stafforini, TM McIntyre, GA Zimmerman, SM Prescott
The Journal of biological chemistry 1997
Mildly Oxidized Low-Density Lipoprotein Impairs Responses of Carotid but Not Basilar Artery in Rabbits
C Napoli, R Paternò, FM Faraci, H Taguchi, A Postiglione, DD Heistad
Stroke; a journal of cerebral circulation 1997
Reactive Oxygen Species and Platelet Activation in Reperfusion Injury
RC Forde, DJ Fitzgerald
Circulation 1997
Oxygen Radicals Can Induce Preconditioning in Rabbit Hearts
I Tritto, D DAndrea, N Eramo, A Scognamiglio, CD Simone, A Violante, A Esposito, M Chiariello, G Ambrosio
Circulation research 1997
Ecto-ATPases
L Plesner, TL Kirley, AF Knowles
1997
Mammalian platelet-activating factor acetylhydrolases
D Stafforini
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1996
Biological effects of diesel exhaust particles (DEP). III. Pathogenesis of asthma like symptoms in mice
M Sagai, A Furuyama, T Ichinose
Free radical biology & medicine 1996
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion
P Golino, M Ragni, P Cirillo, VE Avvdimento, A Feliciello, N Esposito, A Scognamiglio, B Trimarco, G Iaccarino, M Condorelli, M Chiariello, G Ambrosio
Nature Medicine 1996
Platelet-activating-factor-mediated pathogenesis in Lyme disease
E Isogai, K Kimura, N Fujii, T Nishikawa, N Ishii, D Postic, G Baranton, H Isogai
Infection and immunity 1996
Low density lipoprotein oxidation and variant angina: Role of methodologic procedures in assessment of oxidizability of low density lipoprotein
C Napoli
Journal of the American College of Cardiology 1996
APYRASE ADMINISTRATION PROLONGS DISCORDANT XENOGRAFT SURVIVAL1,2,3,4:
N Koyamada, T Miyatake, D Candinas, P Hechenleitner, J Siegel, WW Hancock, FH Bach, SC Robson
Transplantation 1996
The Yin and Yang of Oxidation in the Development of the Fatty Streak: A Review Based on the 1994 George Lyman Duff Memorial Lecture
M Navab, JA Berliner, AD Watson, SY Hama, MC Territo, AJ Lusis, DM Shih, BJ Lenten, JS Frank, LL Demer, PA Edwards, AM Fogelman
Arteriosclerosis, thrombosis, and vascular biology 1996
Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals
C Napoli, M Chiariello, G Palumbo, G Ambrosio
Cardiovascular Drugs and Therapy 1996
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
AD Watson, M Navab, SY Hama, A Sevanian, SM Prescott, DM Stafforini, TM McIntyre, BN Du, AM Fogelman, JA Berliner
Journal of Clinical Investigation 1995
Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells
JM Heery, M Kozak, DM Stafforini, DA Jones, GA Zimmerman, TM McIntyre, SM Prescott
Journal of Clinical Investigation 1995
Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia
C Napoli, A Postiglione, M Triggiani, G Corso, G Palumbo, V Carbone, A Ruocco, G Ambrosio, S Montefusco, A Malorni, M Condorelli, M Chiariello
Atherosclerosis 1995
Platelet-activating factor: a mediator for clinicians
TA Imaizumi, DM Stafforini, Y Yamada, TM Mcintyre, SM Prescott, GA Zimmerman
Journal of Internal Medicine 1995
Cellular Signals in Alcohol-Induced Liver Injury: A Review
WE Lands
Alcoholism, clinical and experimental research 1995
A family of phospholipid autacoids: Occurrence, metabolism and bioactions
A Tokumura
Progress in Lipid Research 1995
Patent Update: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Platelet-activating factor receptor antagonists
A Ayscough, M Whittaker
Expert Opinion on Therapeutic Patents 1995

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts